424 related articles for article (PubMed ID: 26803420)
1. Trends in Complications and Outcomes of Patients Undergoing Transfemoral Transcatheter Aortic Valve Replacement: Experience From the PARTNER Continued Access Registry.
Beohar N; Kirtane AJ; Blackstone E; Waksman R; Holmes D; Minha S; Alli O; Suri RM; Svensson LG; Leon M; Kodali S
JACC Cardiovasc Interv; 2016 Feb; 9(4):355-363. PubMed ID: 26803420
[TBL] [Abstract][Full Text] [Related]
2. Outcomes after transfemoral transcatheter aortic valve replacement: a comparison of the randomized PARTNER (Placement of AoRTic TraNscathetER Valves) trial with the NRCA (Nonrandomized Continued Access) registry.
Fearon WF; Kodali S; Doshi D; Fischbein MP; Yeung AC; Tuzcu EM; Rihal CS; Babaliaros V; Zajarias A; Herrmann HC; Brown DL; Mack M; Teirstein PS; Whisenant BK; Makkar R; Kapadia S; Leon MB;
JACC Cardiovasc Interv; 2014 Nov; 7(11):1245-51. PubMed ID: 25459036
[TBL] [Abstract][Full Text] [Related]
3. Outcomes with post-dilation following transcatheter aortic valve replacement: the PARTNER I trial (placement of aortic transcatheter valve).
Hahn RT; Pibarot P; Webb J; Rodes-Cabau J; Herrmann HC; Williams M; Makkar R; Szeto WY; Main ML; Thourani VH; Tuzcu EM; Kapadia S; Akin J; McAndrew T; Xu K; Leon MB; Kodali SK
JACC Cardiovasc Interv; 2014 Jul; 7(7):781-9. PubMed ID: 25060022
[TBL] [Abstract][Full Text] [Related]
4. Clinical and Functional Outcomes Associated With Myocardial Injury After Transfemoral and Transapical Transcatheter Aortic Valve Replacement: A Subanalysis From the PARTNER Trial (Placement of Aortic Transcatheter Valves).
Paradis JM; Maniar HS; Lasala JM; Kodali S; Williams M; Lindman BR; Damiano RJ; Moon MR; Makkar RR; Thourani VH; Babaliaros V; Xu K; Ayele GM; Svensson L; Leon MB; Zajarias A
JACC Cardiovasc Interv; 2015 Sep; 8(11):1468-1479. PubMed ID: 26404200
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcomes after transcatheter aortic valve replacement in high-risk patients with severe aortic stenosis: the U.K. Transcatheter Aortic Valve Implantation Registry.
Duncan A; Ludman P; Banya W; Cunningham D; Marlee D; Davies S; Mullen M; Kovac J; Spyt T; Moat N
JACC Cardiovasc Interv; 2015 Apr; 8(5):645-53. PubMed ID: 25946435
[TBL] [Abstract][Full Text] [Related]
6. Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement: the PARTNER (Placement of AoRtic TraNscathetER Valves) trial and registry.
Nazif TM; Dizon JM; Hahn RT; Xu K; Babaliaros V; Douglas PS; El-Chami MF; Herrmann HC; Mack M; Makkar RR; Miller DC; Pichard A; Tuzcu EM; Szeto WY; Webb JG; Moses JW; Smith CR; Williams MR; Leon MB; Kodali SK;
JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):60-9. PubMed ID: 25616819
[TBL] [Abstract][Full Text] [Related]
7. European experience with the second-generation Edwards SAPIEN XT transcatheter heart valve in patients with severe aortic stenosis: 1-year outcomes from the SOURCE XT Registry.
Schymik G; Lefèvre T; Bartorelli AL; Rubino P; Treede H; Walther T; Baumgartner H; Windecker S; Wendler O; Urban P; Mandinov L; Thomas M; Vahanian A
JACC Cardiovasc Interv; 2015 Apr; 8(5):657-69. PubMed ID: 25946437
[TBL] [Abstract][Full Text] [Related]
8. Impact of transfemoral versus transapical access on mortality among patients with severe aortic stenosis undergoing transcatheter aortic valve replacement.
Koifman E; Magalhaes M; Kiramijyan S; Escarcega RO; Didier R; Torguson R; Ben-Dor I; Corso P; Shults C; Satler L; Pichard A; Waksman R
Cardiovasc Revasc Med; 2016; 17(5):318-21. PubMed ID: 27394178
[TBL] [Abstract][Full Text] [Related]
9. Pre-Procedural Hemodynamic Status Improves the Discriminatory Value of the Aortic Regurgitation Index in Patients Undergoing Transcatheter Aortic Valve Replacement.
Sinning JM; Stundl A; Pingel S; Weber M; Sedaghat A; Hammerstingl C; Vasa-Nicotera M; Mellert F; Schiller W; Kovac J; Welz A; Grube E; Werner N; Nickenig G
JACC Cardiovasc Interv; 2016 Apr; 9(7):700-11. PubMed ID: 27056309
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Importance of Diastolic Dysfunction in Relation to Post Procedural Aortic Insufficiency in Patients Undergoing Transcatheter Aortic Valve Replacement.
Kampaktsis PN; Bang CN; Chiu Wong S; Skubas NJ; Singh H; Voudris K; Baduashvili A; Pastella K; Swaminathan RV; Kaple RK; Minutello RM; Feldman DN; Kim L; Hriljac I; Lin F; Bergman GS; Salemi A; Devereux RB
Catheter Cardiovasc Interv; 2017 Feb; 89(3):445-451. PubMed ID: 27218599
[TBL] [Abstract][Full Text] [Related]
11. Prospective Multicenter Evaluation of the Direct Flow Medical Transcatheter Aortic Valve System: 12-Month Outcomes of the Evaluation of the Direct Flow Medical Percutaneous Aortic Valve 18F System for the Treatment of Patients With Severe Aortic Stenosis (DISCOVER) Study.
Lefèvre T; Colombo A; Tchétché D; Latib A; Klugmann S; Fajadet J; De Marco F; Maisano F; Bruschi G; Bijuklic K; Nava S; Weissman N; Low R; Thomas M; Young C; Redwood S; Mullen M; Yap J; Grube E; Nickenig G; Sinning JM; Hauptmann KE; Friedrich I; Lauterbach M; Schmoeckel M; Davidson C; Schofer J
JACC Cardiovasc Interv; 2016 Jan; 9(1):68-75. PubMed ID: 26762913
[TBL] [Abstract][Full Text] [Related]
12. One-Year Clinical Outcomes With SAPIEN 3 Transcatheter Aortic Valve Replacement in High-Risk and Inoperable Patients With Severe Aortic Stenosis.
Herrmann HC; Thourani VH; Kodali SK; Makkar RR; Szeto WY; Anwaruddin S; Desai N; Lim S; Malaisrie SC; Kereiakes DJ; Ramee S; Greason KL; Kapadia S; Babaliaros V; Hahn RT; Pibarot P; Weissman NJ; Leipsic J; Whisenant BK; Webb JG; Mack MJ; Leon MB;
Circulation; 2016 Jul; 134(2):130-40. PubMed ID: 27400898
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcomes of percutaneous paravalvular regurgitation closure after transcatheter aortic valve replacement: a multicenter experience.
Saia F; Martinez C; Gafoor S; Singh V; Ciuca C; Hofmann I; Marrozzini C; Tan J; Webb J; Sievert H; Marzocchi A; O'Neill WW
JACC Cardiovasc Interv; 2015 Apr; 8(5):681-8. PubMed ID: 25946440
[TBL] [Abstract][Full Text] [Related]
14. Clinical impact of aortic regurgitation after transcatheter aortic valve replacement: insights into the degree and acuteness of presentation.
Jerez-Valero M; Urena M; Webb JG; Tamburino C; Munoz-Garcia AJ; Cheema A; Dager AE; Serra V; Amat-Santos IJ; Barbanti M; Immè S; Alonso Briales JH; Al Lawati H; Benitez LM; Cucalon AM; Garcia del Blanco B; Revilla A; Dumont E; Barbosa Ribeiro H; Nombela-Franco L; Bergeron S; Pibarot P; Rodés-Cabau J
JACC Cardiovasc Interv; 2014 Sep; 7(9):1022-32. PubMed ID: 25234675
[TBL] [Abstract][Full Text] [Related]
15. Bleeding complications after surgical aortic valve replacement compared with transcatheter aortic valve replacement: insights from the PARTNER I Trial (Placement of Aortic Transcatheter Valve).
Généreux P; Cohen DJ; Williams MR; Mack M; Kodali SK; Svensson LG; Kirtane AJ; Xu K; McAndrew TC; Makkar R; Smith CR; Leon MB
J Am Coll Cardiol; 2014 Mar; 63(11):1100-9. PubMed ID: 24291283
[TBL] [Abstract][Full Text] [Related]
16. Device success and 30-day clinical outcome in patients undergoing preimplant valvuloplasty in transfemoral versus omitting valvuloplasty in transapical transcatheter aortic valve replacement.
Wong SC; Pawar S; Minutello RM; Horn EM; Skubas NJ; Devereux RB; Salemi A
J Thorac Cardiovasc Surg; 2015 Nov; 150(5):1111-7. PubMed ID: 26277463
[TBL] [Abstract][Full Text] [Related]
17. Management of paravalvular regurgitation after Edwards SAPIEN transcatheter aortic valve replacement: management of paravalvular regurgitation after TAVR.
Martinez CA; Singh V; O'Neill BP; Alfonso CE; Bilsker MS; Martinez Clark P; Williams D; Cohen MG; Heldman AW; O'Neill WW
Catheter Cardiovasc Interv; 2013 Aug; 82(2):300-11. PubMed ID: 23580318
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcome and paravalvular leakage of the new balloon-expandable Edwards Sapien 3 valve in comparison to its predecessor model (Edwards Sapien XT) in patients undergoing transfemoral aortic valve replacement.
Bocksch W; Grossmann B; Geisler T; Steeg M; Droppa M; Jorbenadze R; Haap M; Gawaz M; Fateh-Moghadam S
Catheter Cardiovasc Interv; 2016 Sep; 88(3):466-75. PubMed ID: 27184353
[TBL] [Abstract][Full Text] [Related]
19. 1-Year Outcomes With the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients With Severe Aortic Stenosis: Results of the REPRISE II Study.
Meredith IT; Walters DL; Dumonteil N; Worthley SG; Tchétché D; Manoharan G; Blackman DJ; Rioufol G; Hildick-Smith D; Whitbourn RJ; Lefèvre T; Lange R; Müller R; Redwood S; Feldman TE; Allocco DJ; Dawkins KD
JACC Cardiovasc Interv; 2016 Feb; 9(4):376-384. PubMed ID: 26892084
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of patients with chronic lung disease and severe aortic stenosis treated with transcatheter versus surgical aortic valve replacement or standard therapy: insights from the PARTNER trial (placement of AoRTic TraNscathetER Valve).
Dvir D; Waksman R; Barbash IM; Kodali SK; Svensson LG; Tuzcu EM; Xu K; Minha S; Alu MC; Szeto WY; Thourani VH; Makkar R; Kapadia S; Satler LF; Webb JG; Leon MB; Pichard AD
J Am Coll Cardiol; 2014 Jan; 63(3):269-79. PubMed ID: 24140659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
